BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11605098)

  • 21. Tolerance to a new class of non-benzodiazepine anxiolytics.
    Chodera A; Nowakowska E; Bartczak G
    Pol J Pharmacol; 1994; 46(5):479-81. PubMed ID: 7894538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Social instability in female rats: effects on anxiety and buspirone efficacy.
    Haller J; Baranyi J; Bakos N; Halász J
    Psychopharmacology (Berl); 2004 Jul; 174(2):197-202. PubMed ID: 14760513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The consequences of beer consumption in rats: acute anxiolytic and ataxic effects and withdrawal-induced anxiety.
    Gallate JE; Morley KC; Ambermoon P; McGregor IS
    Psychopharmacology (Berl); 2003 Feb; 166(1):51-60. PubMed ID: 12474111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal buspirone protects against the adverse effects of in utero stress on emotional and pain-related behaviors in offspring.
    Butkevich I; Mikhailenko V; Vershinina E; Semionov P; Makukhina G; Otellin V
    Physiol Behav; 2011 Feb; 102(2):137-42. PubMed ID: 21056051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
    Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of cocaine withdrawal-induced anxiety by ondansetron, buspirone and propranolol.
    de Oliveira Citó Mdo C; da Silva FC; Silva MI; Moura BA; Macêdo DS; Woods DJ; Fonteles MM; de Vasconcelos SM; de Sousa FC
    Behav Brain Res; 2012 May; 231(1):116-23. PubMed ID: 22374255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenalectomy modifies the hippocampal 5-HT(1A) receptors and the anxiolytic-like effect of 8-OH-DPAT in rats.
    Briones-Aranda A; Castillo-Salazar M; Picazo O
    Pharmacol Biochem Behav; 2009 Mar; 92(1):182-9. PubMed ID: 19095004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of buspirone and alprazolam treatment on the startle-potentiated startle response.
    Commissaris RL; Fomum EA; Leavell BJ
    Depress Anxiety; 2004; 19(3):146-51. PubMed ID: 15129416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral specificity of non-genomic glucocorticoid effects in rats: effects on risk assessment in the elevated plus-maze and the open-field.
    Mikics E; Barsy B; Barsvári B; Haller J
    Horm Behav; 2005 Aug; 48(2):152-62. PubMed ID: 16042965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Assessment of anxiolytics (4)--Social interaction test].
    Yasumatsu H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Aug; 15(4):295-304. PubMed ID: 7584724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anxiolytic suppression of repetitive transcranial magnetic stimulation-induced anxiety in the rats.
    Isogawa K; Fujiki M; Akiyoshi J; Tsutsumi T; Kodama K; Matsushita H; Tanaka Y; Kobayashi H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):664-8. PubMed ID: 15905012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of environmental enrichment on stress related systems in rats.
    Moncek F; Duncko R; Johansson BB; Jezova D
    J Neuroendocrinol; 2004 May; 16(5):423-31. PubMed ID: 15117335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam.
    Albrechet-Souza L; Cristina de Carvalho M; Rodrigues Franci C; Brandão ML
    Horm Behav; 2007 Aug; 52(2):267-73. PubMed ID: 17553501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Maternal glucocorticoid hormones as a factor mediating the effect of prenatal stress on offspring anxiety].
    Ordian NE; Pivina SG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2003; 53(6):781-3. PubMed ID: 14959493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stress, social avoidance and anxiolytics: a potential model of stress-induced anxiety.
    Haller J; Leveleki C; Baranyi J; Mikics E; Bakos N
    Behav Pharmacol; 2003 Sep; 14(5-6):439-46. PubMed ID: 14501256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pituitary-adrenal axis and the different behavioral effects of buspirone and chlordiazepoxide.
    McNaughton N; Panickar KS; Logan B
    Pharmacol Biochem Behav; 1996 May; 54(1):51-6. PubMed ID: 8728538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors.
    Urigüen L; Pérez-Rial S; Ledent C; Palomo T; Manzanares J
    Neuropharmacology; 2004 Jun; 46(7):966-73. PubMed ID: 15081793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein synthesis and the mechanisms of lasting change in anxiety induced by severe stress.
    Adamec R; Strasser K; Blundell J; Burton P; McKay DW
    Behav Brain Res; 2006 Feb; 167(2):270-86. PubMed ID: 16256211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose dependent effects of serotonergic agents on anxiety.
    Kolcsar M; Gáll Z; Dogaru MT
    Acta Physiol Hung; 2014 Dec; 101(4):479-87. PubMed ID: 25532957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HT-1A receptor responsiveness following subchronic administration of buspirone.
    Khan A; Haleem DJ
    Pak J Pharm Sci; 2006 Oct; 19(4):333-7. PubMed ID: 17105715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.